Search
for

    Sort by

    Research 421–450 of 1000+

    1. Relating neurosteroid modulation of inhibitory neurotransmission to behaviour Journal of Neuroendocrinology · 2021 · 18 citations
    2. Developing a Framework for Sources of New Product Ideas Journal of Consumer Marketing · 1992 · 16 citations
    3. Low-frequency dual-frequency ultrasound-mediated microbubble cavitation for transdermal minoxidil delivery and hair growth enhancement Scientific Reports · 2020 · 14 citations
    4. Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis Acta dermato-venereologica · 2023 · 10 citations
    5. Heat Enhanced Follicular Delivery of Isotretinoin to the Skin Pharmaceutical research · 2019 · 8 citations
    6. A herbal formula, comprising Panax ginseng and bee-pollen, inhibits development of testosterone-induced benign prostatic hyperplasia in male Wistar rats Saudi Journal of Biological Sciences · 2015 · 8 citations
    7. Structural characterization of cyclosporin A, C and microbial bio-transformed cyclosporin A analog AM6 using HPLC–ESI–ion trap-mass spectrometry Talanta · 2014 · 7 citations
    8. Activin A-induced signalling controls hair follicle neogenesis Experimental Dermatology · 2016 · 5 citations
    9. Janus kinase inhibitors for alopecia areata: a review of clinical data Frontiers in Immunology · 2025 · 4 citations
    10. Expression of lipid-protein gene PLP2 in Liaoning cashmere goat Animal biotechnology · 2019 · 3 citations
    11. Microneedles as a perspective for transdermal therapeutic systems Česká a slovenská farmacie · 2019 · 3 citations
    12. Biochemical and Histopathological evaluation of prostatic tissue under effect of Pterostilbene in benign prostatic hyperplasia rat model Al Mustansiriyah Journal of Pharmaceutical Sciences · 2023 · 2 citations
    13. Sebum Production Springer eBooks · 2016 · 1 citations
    14. Scarring Alopecia Actas Dermo-Sifiliográficas · 2012 · 1 citations
    15. Primary cicatricial alopecias Expert Review of Dermatology · 2010 · 1 citations
    16. The genetic basis of dermatophytosis skin infection susceptibility Nature Communications · 2026
    17. Hair Tonic Lotion with Cumaru Extract for Psoriasis Care: in vitro Development and Characterization Journal of Health Sciences · 2025
    18. An Herbal Shampoo Formulation,along with Marketed Product (Clinic Plus) Assessment and Comparison International Journal for Research in Applied Science and Engineering Technology · 2025
    19. MiRNA-24 downregulates KLF6 affecting STAT3 protein expression and phosphorylation regulating melanogenesis in cashmere goat coat Animal Bioscience · 2025
    20. 毛乳頭細胞と毛包上皮細胞間の細胞内・細胞外情報伝達 Institutional Repositories DataBase (IRDB) · 2022
    21. Gene Variant in Amish a Clue to Better Aging Genetic engineering & biotechnology news · 2018
    22. Dermatologic therapy: December 1987 to December 1988 Journal of The American Academy of Dermatology · 1990
    23. A partially automated method for DNA extraction from marmoset hair follicles to avoid blood chimerism Frontiers in Genetics · 2025
    24. A Concise Review on Tissue Engineered Artificial Skin Grafts for Chronic Wound Treatment: Can We Reconstruct Functional Skin Tissue In Vitro? Cells · 2020 · 133 citations
    25. Biomembrane-Based Nanostructure- and Microstructure-Loaded Hydrogels for Promoting Chronic Wound Healing International Journal of Nanomedicine · 2023 · 24 citations
    26. Biocompatible and antibacterial Flammulina velutipes-based natural hybrid cryogel to treat noncompressible hemorrhages and skin defects Frontiers in Bioengineering and Biotechnology · 2022 · 8 citations
    27. Release systems based on self-assembling RADA16-I hydrogels with a signal sequence which improves wound healing processes Scientific Reports · 2023 · 1 citations
    28. ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability Zenodo (CERN European Organization for Nuclear Research) · 2026
    29. ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability Zenodo (CERN European Organization for Nuclear Research) · 2026
    30. Ginsenoside CK inhibits androgenetic alopecia by regulating Wnt/β‐catenin and p53 signaling pathways in AGA mice Food frontiers · 2023